Brevan Howard Capital Management’s ResMed RMD Stock Holding History

Brevan Howard Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$512K	Sell	2,283 -203	-8%	-$50.6K	﹤0.01%	1292
2025 Q4	$599K	Buy	+2,486	New	+$636K	0.01%	1011
2025 Q3	–	Sell	-12,160	Closed	-$3.14M	–	2226
2025 Q2	$3.14M	Buy	+12,160	New	+$2.9M	0.02%	556
2025 Q1	–	Sell	-6,726	Closed	-$1.54M	–	1411
2024 Q4	$1.54M	Buy	+6,726	New	+$1.62M	0.01%	334
2024 Q3	–	Sell	-6,111	Closed	-$1.17M	–	1391
2024 Q2	$1.17M	Buy	+6,111	New	+$1.24M	0.01%	330

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Brevan Howard Capital Management's RMD Position: Q1 2026 in Review

Brevan Howard Capital Management reduced its ResMed (RMD) stake by 8.2% in Q1 2026, selling an estimated $50.6K and leaving 2,283 shares worth $512K. The position accounts for ﹤0.01% of the portfolio, ranked #1292.

Brevan Howard Capital Management first reported a position in RMD in Q2 2024 and has held it in 5 quarters since. The position peaked at $3.14M in Q2 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Brevan Howard Capital Management held 2,283 shares of ResMed worth $512K as of Q1 2026.
Brevan Howard Capital Management sold 203 ResMed shares in Q1 2026, an estimated $50.6K.
ResMed made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1292 holding.
Brevan Howard Capital Management first reported a position in ResMed in Q2 2024 and has held it in 5 quarters since.
Brevan Howard Capital Management's ResMed position peaked at $3.14M in Q2 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.